267 related articles for article (PubMed ID: 20486800)
1. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.
Hånell A; Clausen F; Björk M; Jansson K; Philipson O; Nilsson LN; Hillered L; Weinreb PH; Lee D; McIntosh TK; Gimbel DA; Strittmatter SM; Marklund N
J Neurotrauma; 2010 Jul; 27(7):1297-309. PubMed ID: 20486800
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice.
Tong J; Liu W; Wang X; Han X; Hyrien O; Samadani U; Smith DH; Huang JH
J Neurotrauma; 2013 Feb; 30(4):247-58. PubMed ID: 22967270
[TBL] [Abstract][Full Text] [Related]
4. Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice.
Marklund N; Morales D; Clausen F; Hånell A; Kiwanuka O; Pitkänen A; Gimbel DA; Philipson O; Lannfelt L; Hillered L; Strittmatter SM; McIntosh TK
Neuroscience; 2009 Oct; 163(2):540-51. PubMed ID: 19555742
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity.
Raiker SJ; Lee H; Baldwin KT; Duan Y; Shrager P; Giger RJ
J Neurosci; 2010 Sep; 30(37):12432-45. PubMed ID: 20844138
[TBL] [Abstract][Full Text] [Related]
6. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
[TBL] [Abstract][Full Text] [Related]
7. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
Cafferty WB; Duffy P; Huebner E; Strittmatter SM
J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
[TBL] [Abstract][Full Text] [Related]
9. Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury.
Liu G; Ni J; Mao L; Yan M; Pang T; Liao H
Brain Res; 2015 Nov; 1627():41-51. PubMed ID: 26367446
[TBL] [Abstract][Full Text] [Related]
10. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury.
Yang J; Han Y; Ye W; Liu F; Zhuang K; Wu G
J Surg Res; 2013 Jun; 182(2):e69-77. PubMed ID: 23207171
[TBL] [Abstract][Full Text] [Related]
11. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
12. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
[TBL] [Abstract][Full Text] [Related]
14. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats.
Lenzlinger PM; Shimizu S; Marklund N; Thompson HJ; Schwab ME; Saatman KE; Hoover RC; Bareyre FM; Motta M; Luginbuhl A; Pape R; Clouse AK; Morganti-Kossmann C; McIntosh TK
Neuroscience; 2005; 134(3):1047-56. PubMed ID: 15979242
[TBL] [Abstract][Full Text] [Related]
15. Neuronal overexpression of Nogo receptor 1 in APPswe/PSEN1(ΔE9) mice impairs spatial cognition tasks without influencing plaque formation.
Karlsson TE; Karlén A; Olson L; Josephson A
J Alzheimers Dis; 2013; 33(1):145-55. PubMed ID: 22903127
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Nogo-66 receptor 1 function in vivo after spinal cord injury.
Tong J; Ren Y; Wang X; Dimopoulos VG; Kesler HN; Liu W; He X; Nedergaard M; Huang JH
Neurosurgery; 2014 Jul; 75(1):51-60. PubMed ID: 24594926
[TBL] [Abstract][Full Text] [Related]
17. Expression of NgR1-antagonizing proteins decreases with aging and cognitive decline in rat hippocampus.
VanGuilder Starkey HD; Bixler GV; Sonntag WE; Freeman WM
Cell Mol Neurobiol; 2013 May; 33(4):483-8. PubMed ID: 23525710
[TBL] [Abstract][Full Text] [Related]
18. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice.
Fink KL; Strittmatter SM; Cafferty WB
J Neurosci; 2015 Nov; 35(46):15403-18. PubMed ID: 26586827
[TBL] [Abstract][Full Text] [Related]
20. Nogo receptor is involved in the adhesion of dendritic cells to myelin.
McDonald CL; Steinbach K; Kern F; Schweigreiter R; Martin R; Bandtlow CE; Reindl M
J Neuroinflammation; 2011 Sep; 8():113. PubMed ID: 21906273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
